Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 18.52% Profit

May 03, 2023
ELI LILLY AND COMPANY stock has successfully achieved the price target forecast as predicted by QuantWave's automated forecasting platform. On January 3, the forecast signal indicated a long position with the stock priced at 356.95 $. Fast forward to May 3, and the stock reached the target price of 423.05 $, resulting in a profit of 18.52%.

This achievement underscores the accuracy and reliability of QuantWave's analytics in predicting market movements. In a volatile market environment, such precise forecasts provide investors with valuable insights to make informed trading decisions.

Several factors may have contributed to ELI LILLY AND COMPANY's stock movement, including positive developments in the pharmaceutical industry, company-specific news, and overall market trends. It is essential for investors to consider these factors and leverage quantitative analysis tools like QuantWave to optimize their investment strategies.

QuantWave's automated forecasting platform offers users access to predictions for a wide range of stocks, presenting opportunities for potential profits. For investors seeking to enhance their understanding of the market and maximize returns, QuantSchool provides a comprehensive professional investment framework. By leveraging QuantWave's forecasting system and following QuantSchool's key principles, investors can generate consistent income and achieve their financial goals.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 8, 2025ELI LILLY AND COMPANY Hits Price Target Forecast with 18.31% Profit - QuantWave Achieves Success Once Again  ~2 min.

ELI LILLY AND COMPANY, one of the leading pharmaceutical companies, recently saw its stock price hitting the forecasted target with a profit of 18.31% as predicted by QuantWave on June 4, 2025....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast as QuantWave Users Gain 17.38% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved the price target forecast set by QuantWave, marking a significant success for users of the automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Target Forecast with 17.25% Profit: A Success Story for QuantWave  ~2 min.

ELI LILLY AND COMPANY, a leading pharmaceutical company, recently saw its stock hit the target forecast set by QuantWave, yielding a profit of 17.25%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Profit of 23.55%: A Success Story for QuantWave  ~2 min.

ELI LILLY AND COMPANY, a prominent player in the pharmaceutical industry, recently achieved a significant milestone by hitting a price target forecast generated by the innovative forecasting platform, QuantWave. The forecast, which indicated a short direction signal on April 17, 2025, at a price of 836.4 USD, proved to be accurate as the stock reached the predicted target price of 639.46 USD on Au...


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Target Forecast with 22.13% Profit  ~1 min.

ELI LILLY AND COMPANY stock successfully reached the forecasted target price of 639.46 $ on August 7, 2025, resulting in a profit of 22.13% for investors....


LLYAugust 1, 2025Eli Lilly and Company Completes Acquisition of Verve Therapeutics, Advancing One-Time Treatments for High Cardiovascular Risk  ~1 min.

Eli Lilly and Company has announced the successful completion of its acquisition of Verve Therapeutics, a move that will help advance innovative one-time treatments for individuals with high cardiovascular risk. This strategic decision showcases the company's commitment to revolutionizing the healthcare industry and improving patient outcomes. Investors are eagerly watching as Eli Lilly continues ...


LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Stock Hits Forecasted Price Target with 8.64% Profit  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) stock successfully reached the forecasted price target set by QuantWave on 2025-06-20, with a predicted long direction. The stock was valued at 440....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 34.08% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. stock successfully reached the price target forecast set by QuantWave on May 30, 2025. The forecast signal was initiated on March 10, 2025, with a price of 742.6 $....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.52% Profit  ~2 min.

REGENERON PHARMACEUTICALS, INC. stock has successfully reached the price target forecast set by QuantWave on April 4, 2025....


VRTXAugust 8, 2025VERTEX PHARMACEUTICALS Stock Hits Target Price with 10.23% Profit: QuantWave Forecast Success  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED stock recently reached its forecasted target price of 366.54 $, generating a profit of 10.23% for investors....


REGNAugust 15, 2024REGENERON PHARMACEUTICALS, INC. Achieves Price Target Forecast with 18.25% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave, with a profit of 18.25%....